We Have News
High-Dose Stem Cell Transfer Here We Come
Just saw my oncologist at Moffitt. The good news: I won’t be undergoing Cisplatin-based chemo anytime soon, so I get a little break. The rest: this is one intense treatment I’m in for. My seminoma is among the 1% of seminoma that didn’t respond to the first line treatment. There wasn’t any confidence that a second line treatment would get it to respond …